Application Specialist 2

FMA chair James Miller quits Vista, Ryman boards amid conflict concerns. Tue, 11 Aug 2026 0 Comments / 0 New James Miller is the new chair of the Financial Markets Authority. (Image: Supplied) New Financial Markets Authority chair James Miller will step down from the boards of Vista Group and Ryman Healthcare, days after his appointment sparked debate about potential conflicts of interest arising from his ties to listed companies. Both NZX-listed companies announced on Tuesday that Miller would leave their boards following his appointment to lead the market regulator. Miller took up the role on Aug 6 for a five-year term, succeeding former Financial Markets Authority (FMA) chair Craig Stobo. The departures come as som... * Deeply researched, twice-edited and fact-checked news * Annual subscribers also receive a complimentary subscription to The Wall Street Journal * Personalised email news alerts, plus gift up to 5 stories a month to non-subscribers Minimum password length of 8 characters. Require at least one upper and lowercase, numeric, and special character. Annual - including full access to The Wall Street Journal $349.00 Monthly $44.00 All subscriptions auto renew but are easy to cancel. Not convinced yet? Markets sponsored by Award-winning investment expertise, trusted to deliver for the long term Kōura's Clean Energy Fund returned 97.9% over 12 months to June 30. LDW allegedly had $59m in undisclosed external borrowing, documents show. Our fortnightly round-up of public sector news and reckons. The critical pipeline supports more than 10% of New Zealand's fuel supply. Inside the discipline behind three decades of growth. First Mortgage Trust New Financial Markets Authority chair James Miller will step down from the boards of Vista Group and Ryman Healthcare, days after his appointment sparked debate about potential conflicts of interest arising from his ties to listed companies. Both NZX-listed companies announced on Tuesday that Miller would leave their boards following his appointme Rebecca Stevenson 11 Aug 2026 Commerce and Consumer Affairs Minister Cameron Brewer says he is satisfied conflict-of-interest safeguards at the Financial Markets Authority are robust enough to manage concerns about the outside roles held by several of the regulator's board members. The minister's response follows questions about whether new chair James Miller's listed-company Rebecca Stevenson 10 Aug 2026 By Tim Higgins SpaceX may be a rocket company, but nowadays it feels more like a roller coaster. This past week alone, chief executive Elon Musk watched as its shares plummeted almost 14% in one day - which wasn't even the worst performance in SpaceX's short tenure as a publicly traded company. By Friday, the shares had soared more than 20% from The Wall Street Journal 10 Aug 2026 Brent Pattison has been the chief executive of Heritage Lifecare since 2025. He was also previously the CEO of NZX-listed Oceania Healthcare, and his career spans aged care, investment banking, and corporate strategy. He is the father of two adult sons and has two grandchildren. He lives in Auckland. I was born in Wellington Hospital. My mum was a Jacques Steenkamp 08 Aug 2026 James Miller has been appointed as the chair of the Financial Markets Authority. Miller, who has extensive experience in capital markets and corporate governance, was selected for the role as the Financial Markets Authority (FMA) takes on its expanded responsibilities, Finance Minister Nicola Willis said. He has been appointed for a five-year term, BD AI 06 Aug 2026 The Government appointed a new chair of the Financial Markets Authority on Thursday, as the financial markets regulator grapples with concerns over workplace cultural issues that risk overshadowing its watchdog role. Finance Minister Nicola Willis described the new Financial Markets Authority (FMA) chair, James Miller, as "one of this country's mos Rachel Pannett 06 Aug 2026 It began with two big names and ended with a question hanging over New Zealand's capital markets: is there enough work to support another major investment bank? In the space of a week, Australian investment bank Barrenjoey announced its New Zealand launch, recruited Jarden heavyweights Silvana Schenone and Dan Reynolds to lead the business, and spa Rebecca Stevenson 06 Aug 2026 Had Colin Hurst not suffered two Achilles injuries, he may never have become president of Federated Farmers. The South Canterbury cropping farmer had stepped away from the organisation before the two injuries, the second requiring surgery just before Covid-19, left him sidelined with time on his hands. "I didn't have anything to do, so then I rang Riley Kennedy 31 Jul 2026 By Becky Peterson and Micah Maidenberg A month ago, Elon Musk was crowned the world's first trillionaire after a record public offering for SpaceX. Now investors are growing impatient with the pioneering businessman as the bills come due on his most ambitious promises for SpaceX and Tesla. Tesla shares fell 14.5% on Thursday - erasing US$215 billio The Wall Street Journal 24 Jul 2026 John Harbord, a frequent critic of the gentailers and the market regulator, has been appointed as chair of the Electricity Authority. His three-year appointment ends a period of uncertainty in the governance of the market regulator, Electricity Authority (EA), which has been without a chair since Anna Kominik resigned late last year. In the past, Ian Llewellyn 15 Jul 2026

Xianheng International Science & Technology is trading at a discount to its estimated fair value based on cash flows, according to a screening of undervalued Asian stocks. The company appears on a list of 196 stocks identified as potentially undervalued relative to their future cash flow projections. The screening comes as Asian markets face rising inflation pressures from higher energy costs, alongside geopolitical uncertainties and fluctuating commodity prices. Investors are seeking opportunities in undervalued stocks with strong fundamentals across resilient sectors. Other companies on the list include Vista Group International, which is trading 30.8% below its estimated fair value, with earnings forecast to grow 40.2% annually. The screening methodology focuses on identifying stocks trading below their estimated future cash flow values.